Article
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.
Leukemia - 1 Jul 2024
Malcikova Jitka, Pavlova Sarka, Baliakas Panagiotis, Chatzikonstantinou Thomas, Tausch Eugen, Catherwood Mark, Rossi Davide, Soussi Thierry, Tichy Boris, Kater Arnon P, Niemann Carsten U, Davi Frederic, Gaidano Gianluca, Stilgenbauer Stephan, Rosenquist Richard, Stamatopoulos Kostas, Ghia Paolo, Pospisilova Sarka
Abstract excerpt
In chronic lymphocytic leukemia (CLL), analysis of TP53 aberrations (deletion and/or mutation) is a crucial part of treatment decision-making algorithms. Technological and treatment advances have resulted in the need for an update of the last recommendations for TP53 analysis in CLL, published by ERIC, the European Research Initiative on CLL, in 2018. Based on the current knowledge of the relevance of low-burden...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
